Antigenicity of recombinant proteins derived from Plasmodium falciparum merozoite surface protein 1

被引:49
作者
Cavanagh, DR
McBride, JS
机构
[1] Institute of Cell, Division of Biological Sciences, University of Edinburgh, West Mains Road, Edinburgh
基金
英国惠康基金;
关键词
malaria; Plasmodium falciparum; antibody; recombinant antigens;
D O I
10.1016/S0166-6851(96)02826-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have expressed seven recombinant antigens representing two N-terminal regions of the polymorphic merozoite surface protein 1 (MSP-1) of Plasmodium falciparum. The antigens include the MAD20 and Palo Alto forms of the relatively conserved Block 1 region, and variants of the Block 2 region from isolates 3D7, Palo Alto FUP, MAD20, Wellcome and RO33, that are representative of a range of amino acid sequence diversity in this most polymorphic section of MSP-1. All recombinant antigens have been able to immunise mice to produce polyclonal antibodies which specifically recognise parasite MSP-1 in indirect immunofluorescence assays and in Western blots. The recombinant antigens also react appropriately in ELISA with murine monoclonal antibodies specific for variant epitopes in Block 2 of MSP-1. These results show that the antigenic structure of the recombinant proteins is similar to that of the native MSP-1 product from parasites. Importantly, human sera from malaria-exposed individuals contain IgG antibodies that recognise very specifically one or another of the Block 2 types, showing that different Block 2 types are immunogenic, antigenically distinct and distinguishable when presented during natural infections. In contrast, the conserved Block 1 is rarely recognised by human antibodies. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:197 / 211
页数:15
相关论文
共 47 条
[1]  
ALESSANDRO UD, 1995, LANCET, V346, P462
[2]   THE 1ST FIELD TRIALS OF THE CHEMICALLY SYNTHESIZED MALARIA VACCINE SPF66 - SAFETY, IMMUNOGENICITY AND PROTECTIVITY [J].
AMADOR, R ;
MORENO, A ;
VALERO, V ;
MURILLO, L ;
MORA, AL ;
ROJAS, M ;
ROCHA, C ;
SALCEDO, M ;
GUZMAN, F ;
ESPEJO, F ;
NUNEZ, F ;
PATARROYO, ME .
VACCINE, 1992, 10 (03) :179-184
[5]   A SINGLE FRAGMENT OF A MALARIA MEROZOITE SURFACE PROTEIN REMAINS ON THE PARASITE DURING RED-CELL INVASION AND IS THE TARGET OF INVASION-INHIBITING ANTIBODIES [J].
BLACKMAN, MJ ;
HEIDRICH, HG ;
DONACHIE, S ;
MCBRIDE, JS ;
HOLDER, AA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (01) :379-382
[6]   EXPRESSION OF THE 19-KILODALTON CARBOXY-TERMINAL FRAGMENT OF THE PLASMODIUM-FALCIPARUM MEROZOITE SURFACE PROTEIN-1 IN ESCHERICHIA-COLI AS A CORRECTLY FOLDED PROTEIN [J].
BURGHAUS, PA ;
HOLDER, AA .
MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 1994, 64 (01) :165-169
[7]   A NATURALLY-OCCURRING GENE ENCODING THE MAJOR SURFACE-ANTIGEN PRECURSOR P190 OF PLASMODIUM-FALCIPARUM LACKS TRIPEPTIDE REPEATS [J].
CERTA, U ;
ROTMANN, D ;
MATILE, H ;
REBERLISKE, R .
EMBO JOURNAL, 1987, 6 (13) :4137-4142
[8]   PLASMODIUM-FALCIPARUM - GENE STRUCTURE AND HYDROPATHY PROFILE OF THE MAJOR MEROZOITE SURFACE-ANTIGEN (GP195) OF THE UGANDA-PALO-ALTO ISOLATE [J].
CHANG, SP ;
KRAMER, KJ ;
YAMAGA, KM ;
KATO, A ;
CASE, SE ;
SIDDIQUI, WA .
EXPERIMENTAL PARASITOLOGY, 1988, 67 (01) :1-11
[9]   A recombinant Baculovirus 42-kilodalton c-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria [J].
Chang, SP ;
Case, SE ;
Gosnell, WL ;
Kramer, KJ ;
Tam, LQ ;
Hashiro, CQ ;
Nikaido, CM ;
Gibson, HL ;
LeeNg, CT ;
Barr, PJ ;
Yokota, BT ;
Hui, GSN .
INFECTION AND IMMUNITY, 1996, 64 (01) :253-261
[10]   NATURAL ANTIBODIES AGAINST 3 DISTINCT AND DEFINED ANTIGENS OF PLASMODIUM-FALCIPARUM IN RESIDENTS OF A MESOENDEMIC AREA IN GABON [J].
CHIZZOLINI, C ;
DUPONT, A ;
AKUE, JP ;
KAUFMANN, MH ;
VERDINI, AS ;
PESSI, A ;
DELGIUDICE, G .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1988, 39 (02) :150-156